Joshua Boger News
Most Popular Joshua Boger Story
Vertex CEO resigns as telaprevir advances
After two decades at the helm of Vertex Pharmaceuticals, CEO Dr. Joshua Boger announced that he will retire in May. Shire chairman Matthew Emmens will take over the top spot after Boger's departure Read more...
Latest Headlines
- April 7, 2009
- February 11, 2009
- February 6, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
